Biotech · Private company
Progenics Pharmaceuticals, Inc.
Track this companyFree. Adds Progenics Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials227 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- 18F-DCFPyLPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- 18F-DCFPyL InjectionPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- PET/CT imagingPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- EnzalutamidePhase 2 · Metastatic Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- I-131-1095Phase 2 · Metastatic Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials22
- 177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic CarcinomaPHASE2 · TERMINATED · started Feb 10, 2025ClinicalTrials.gov NCT06322576 · fetched Nov 12, 2026
- Breast Cancer PSMA PETEARLY_PHASE1 · RECRUITING · started Aug 29, 2024ClinicalTrials.gov NCT06586047 · fetched Nov 12, 2026
- Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal TherapyPHASE4 · RECRUITING · started Jun 25, 2024ClinicalTrials.gov NCT05919329 · fetched Nov 12, 2026
- Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide TetraxetanPHASE4 · RECRUITING · started Apr 1, 2024ClinicalTrials.gov NCT06099093 · fetched Nov 12, 2026
- A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine TumorsPHASE1_PHASE2 · WITHDRAWN · started Sep 30, 2022ClinicalTrials.gov NCT04614766 · fetched Nov 12, 2026
- Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate CancerPHASE2 · TERMINATED · started Feb 11, 2022ClinicalTrials.gov NCT04984343 · fetched Nov 12, 2026
- 18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate CancerPHASE2 · TERMINATED · started May 1, 2021ClinicalTrials.gov NCT04727736 · fetched Nov 12, 2026
- High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical ProstatectomyPHASE2 · TERMINATED · started Apr 6, 2021ClinicalTrials.gov NCT04461509 · fetched Nov 12, 2026
- Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate CancerPHASE3 · TERMINATED · started Aug 14, 2020ClinicalTrials.gov NCT04457245 · fetched Nov 12, 2026
- PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test ScoresPHASE2_PHASE3 · RECRUITING · started Dec 18, 2019ClinicalTrials.gov NCT03495427 · fetched Nov 12, 2026
- Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA LigandEARLY_PHASE1 · COMPLETED · started Dec 16, 2019ClinicalTrials.gov NCT04266392 · fetched Nov 12, 2026
- Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate CancerACTIVE_NOT_RECRUITING · started Jul 19, 2019ClinicalTrials.gov NCT04030338 · fetched Nov 12, 2026
- I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).PHASE2 · COMPLETED · started May 30, 2019ClinicalTrials.gov NCT03939689 · fetched Nov 12, 2026
- Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate CancerPHASE3 · COMPLETED · started Nov 27, 2018ClinicalTrials.gov NCT03739684 · fetched Nov 12, 2026
- PET/MRI for the Staging of Newly Diagnosed Prostate CancerEARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started Jun 8, 2018ClinicalTrials.gov NCT03392181 · fetched Nov 12, 2026
- Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 29, 2018ClinicalTrials.gov NCT03471650 · fetched Nov 12, 2026
- Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate CancerPHASE2_PHASE3 · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02981368 · fetched Nov 12, 2026
- A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant PainPHASE3 · COMPLETED · started Sep 1, 2010ClinicalTrials.gov NCT01186770 · fetched Nov 12, 2026
- Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer SubjectsPHASE4 · WITHDRAWN · started Mar 1, 2009ClinicalTrials.gov NCT00858754 · fetched Nov 12, 2026
- A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia RepairPHASE3 · COMPLETED · started Oct 17, 2007ClinicalTrials.gov NCT00528970 · fetched Nov 12, 2026
- Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant PainPHASE2 · COMPLETED · started Oct 1, 2007ClinicalTrials.gov NCT00547586 · fetched Nov 12, 2026
- Study Evaluating Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic Non-Malignant PainPHASE3 · COMPLETED · started Aug 1, 2007ClinicalTrials.gov NCT00529087 · fetched Nov 12, 2026